References

Abel F et al. (1999) Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24. Br J Cancer 81:1402-1409 Ambros I et al. (1996) Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 334:1505-1511 Ambros PF, Ambros IM (2001) Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37:492-504 Berthold F, Harms D, Lampert F, Niethammer D, Zieschang J (1990) Risk factors in neuroblastoma of infants. Contrib Oncol 41:101-117 Berthold F et al. (1992a) Prognostic factors in metastatic neu-roblastoma. A multivariate analysis of 182 cases. Am J Pedi-atr Hematol Oncol 14:207-215 Berthold F et al. (1992b) Serum vanillylmandelic acid/ho-movanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblas-toma. Eur J Cancer 28A:1950-1954 Berthold F et al. (1994) Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Pediatr Hematol Oncol 16:107-115 Berthold F et al. (1998) Are spontaenous regressions of neu-roblastoma delayed embryofetal involutions? Sind Spontanregressionen beim Neuroblastom versp├Ątete embryofetale Involutionen? In: Hein E, Schwarz, Stuttgard R (eds) Spontanremissionen in der Onkologie: theoretische Modelle und klinische Befunde. Schattauer, New York,pp 84-94 Bown N et al. (1999) Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med

340:1954-1961

Brodeur GM et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477 Brodeur GM et al. (1997) Biology and genetics of human neu-

roblastomas. J Pediatr Hematol Oncol 19:93-101 Castleberry RP et al. (1994) The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group. J Clin Oncol 12:2378-2381 Cohn SL et al. (1995) Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pedi-atric Oncology Group study. Cancer Res 55:721-726 Combaret V et al. (1996) Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 14:

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment